Tim Wilsdon recently presented at an education forum at ISPOR Latin America, talking about the challenges that gene therapy poses for value assessment and considerations for the future.
For more information about the conference, click here.
Patient burden associated with acute & chronic resistant infections
Antimicrobial resistance (AMR) imposes a significant burden on patients facing both acute and chronic infections.